Literature DB >> 2523941

Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.

M Perez1, R Edelson, L Laroche, C Berger.   

Abstract

Induction of tolerance for skin allotransplantation requires selective suppression of the host response to foreign histocompatibility antigens. This report describes a new approach that employs pretreatment of effector cells with 8-methoxy-psoralen (8-MOP) and ultraviolet A light (UVA) to render the effector cells of graft rejection immunogenic for the syngeneic recipient. Reinfusion of photodamaged cells resulted in an immunosuppressive host response that permitted prolonged retention of histoincompatible skin grafts and specifically inhibited in vitro and in vivo responses that correlate with allograft rejection. Eight days after BALB/c mice received CBA/j skin grafts, their splenocytes served as a source of alloreactive effector cells. The splenocytes were treated with 100 ng/ml 8-MOP and 1 J/cm2 UVA before reinfusion into naive BALB/c recipients. Recipient mice were tested for tolerance to alloantigens in mixed leukocyte culture (MLC), cytotoxicity (CTL), delayed type hypersensitivity assays (DTH), and challenge with a fresh CBA/j graft. Splenocytes from BALB/c recipients of photoinactivated splenocytes containing the effector cells of CBA/j alloantigen rejection proliferated poorly in MLC and generated lower cytotoxic T cell responses to CBA/j alloantigens in comparison with sensitized and naive controls. Splenocytes from these hyporesponsive mice suppressed the MLC and CTL response to alloantigen from sensitized and naive BALB/c mice. In vivo the DTH response was specifically suppressed to the relevant alloantigen in comparison with controls. Moreover, BALB/c mice treated in this fashion retained a CBA/j skin graft for up to 42 d posttransplantation without visual evidence of rejection. These results indicate that the in vivo and in vitro response to alloantigen can be attenuated by pretreating the host with photoinactivated splenocytes containing the effector cells of alloantigen rejection.

Entities:  

Mesh:

Year:  1989        PMID: 2523941     DOI: 10.1111/1523-1747.ep12696853

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.

Authors:  M Di Renzo; P Rubegni; G De Aloe; L Paulesu; A L Pasqui; L Andreassi; A Auteri; M Fimiani
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

2.  Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations.

Authors:  R M Knobler
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.

Authors:  Paolo Perseghin
Journal:  Transfus Med Hemother       Date:  2007-12-21       Impact factor: 3.747

Review 4.  Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

Review 5.  Novel therapies for pemphigus vulgaris: an overview.

Authors:  Oliver A Perez; Timothy Patton
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Treatment of severe atopic dermatitis with extracorporeal photopheresis.

Authors:  B Prinz; F Nachbar; G Plewig
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.

Authors:  B Prinz; W Behrens; E Hölzle; G Plewig
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary report.

Authors:  A H Rook; P W Heald; G T Nahass; W Macey; W K Witmer; G S Lazarus; B V Jegasothy
Journal:  Yale J Biol Med       Date:  1989 Nov-Dec

Review 9.  Photopheresis: a new therapeutic concept.

Authors:  R L Edelson
Journal:  Yale J Biol Med       Date:  1989 Nov-Dec

10.  Loss of epidermal integrity by T cell-mediated attack induces long-term local resistance to subsequent attack. I. Induction of resistance correlates with increases in Thy-1+ epidermal cell numbers.

Authors:  T Shiohara; N Moriya; C Gotoh; J Hayakawa; M Nagashima; K Saizawa; H Ishikawa
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.